{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:04:18Z","timestamp":1791378258994,"version":"4.3.2"},"reference-count":38,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["RC 2022\u20132024"],"award-info":[{"award-number":["RC 2022\u20132024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Increased anandamide levels via fatty acid amide hydrolase (FAAH) inhibition can decrease the pronociceptive responses and inflammatory mediators in animal models of migraine. Here, we profile the pharmacological activity of the FAAH inhibitor JZP327A, a chiral 1,3,4-oxadiazol-2(3H)-one compound, in the mediation of spontaneous and nocifensive behaviour in the animal models of migraine based on nitroglycerin (NTG) administration. JZP327A (0.5 mg\/kg, i.p.) or vehicle was administered to male rats 3 h after NTG (10 mg\/kg, i.p.) or NTG vehicle injection. The rats were then exposed to the open field test and an orofacial formalin test 1 h later. The levels of endocannabinoids and lipid-related substances, and the expression of pain and inflammatory mediators were evaluated in cranial tissues and serum. The findings show that JZP327A did not affect NTG-induced changes in the spontaneous behaviour of rats, while it inhibited NTG-induced hyperalgesia at the orofacial formalin test. Furthermore, JZP327A dramatically decreased the gene expression of calcitonin gene-related peptide (CGRP), tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) in the trigeminal ganglia and medulla-pons, while it did not change endocannabinoids or lipids levels nor CGRP serum levels in the same tissues. These data suggest an anti-hyperalgesic role for JZP327A in the NTG model, which is mediated by the inhibition of the inflammatory cascade of events. This activity does not seem mediated by a change in the levels of endocannabinoids and lipid amides.<\/jats:p>","DOI":"10.3390\/ijms241210102","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T02:01:40Z","timestamp":1686708100000},"page":"10102","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine"],"prefix":"10.3390","volume":"24","author":[{"given":"Rosaria","family":"Greco","sequence":"first","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4483-3368","authenticated-orcid":false,"given":"Miriam","family":"Francavilla","sequence":"additional","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, Italy"},{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-7773","authenticated-orcid":false,"given":"Chiara","family":"Demartini","sequence":"additional","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, Italy"},{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Zanaboni","sequence":"additional","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, Italy"},{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Facchetti","sequence":"additional","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Palmisani","sequence":"additional","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, Italy"},{"name":"Clinical and Experimental Pharmacology Unit, Department of Internal Medicine and Therapeutics, University of Pavia, Via Ferrata 9\/A, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Franco","sequence":"additional","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, Italy"},{"name":"Clinical and Experimental Pharmacology Unit, Department of Internal Medicine and Therapeutics, University of Pavia, Via Ferrata 9\/A, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-2113","authenticated-orcid":false,"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[{"name":"Section of Translational Neurovascular Research, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, Italy"},{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Via Bassi 21, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.expneurol.2010.03.029","article-title":"The Endocannabinoid System and Migraine","volume":"224","author":"Greco","year":"2010","journal-title":"Exp. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0972-2327.182302","article-title":"Understanding Migraine: Potential Role of Neurogenic Inflammation","volume":"19","author":"Malhotra","year":"2016","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid Signaling as a Synaptic Circuit Breaker in Neurological Disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat. Med."},{"key":"ref_4","first-page":"607","article-title":"Review of the Endocannabinoid System","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(91)90017-P","article-title":"Cannabinoid-Induced Antinociception Is Mediated by a Spinal A2-Noradrenergic Mechanism","volume":"559","author":"Lichtman","year":"1991","journal-title":"Brain Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the Expanded Endocannabinoid System in Neurological Disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.euroneuro.2015.04.001","article-title":"Inhibition of FAAH Reduces Nitroglycerin-Induced Migraine-like Pain and Trigeminal Neuronal Hyperactivity in Mice","volume":"25","author":"Nozaki","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104624","DOI":"10.1016\/j.nbd.2019.104624","article-title":"FAAH Inhibition as a Preventive Treatment for Migraine: A Pre-Clinical Study","volume":"134","author":"Greco","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105157","DOI":"10.1016\/j.nbd.2020.105157","article-title":"Characterization of the Peripheral FAAH Inhibitor, URB937, in Animal Models of Acute and Chronic Migraine","volume":"147","author":"Greco","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s10194-022-01449-1","article-title":"Potentiation of Endocannabinoids and Other Lipid Amides Prevents Hyperalgesia and Inflammation in a Pre-Clinical Model of Migraine","volume":"23","author":"Greco","year":"2022","journal-title":"J. Headache Pain"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kakkar, S., and Narasimhan, B. (2019). A Comprehensive Review on Biological Activities of Oxazole Derivatives. BMC Chem., 13.","DOI":"10.1186\/s13065-019-0531-9"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"111953","DOI":"10.1016\/j.ejmech.2019.111953","article-title":"A Perspective Review on Fatty Acid Amide Hydrolase (FAAH) Inhibitors as Potential Therapeutic Agents","volume":"188","author":"Tripathi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0333102414566862","article-title":"Effects of Peripheral FAAH Blockade on NTG-Induced Hyperalgesia\u2014Evaluation of URB937 in an Animal Model of Migraine","volume":"35","author":"Greco","year":"2015","journal-title":"Cephalalgia"},{"key":"ref_14","first-page":"1138","article-title":"The Effect of the Enzyme Inhibitor Phenylmethylsulfonyl Fluoride on the Pharmacological Effect of Anandamide in the Mouse Model of Cannabimimetic Activity","volume":"283","author":"Compton","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Greco, R., Demartini, C., Francavilla, M., Zanaboni, A.M., and Tassorelli, C. (2021). Dual Inhibition of Faah and Magl Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine. Cells, 10.","DOI":"10.3390\/cells10102543"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1021\/jm021119g","article-title":"Design, Synthesis, and Structure\u2212Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors","volume":"46","author":"Tarzia","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1021\/jm701631z","article-title":"Synthesis and Quantitative Structure\u2212Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-Yl Alkylcarbamates","volume":"51","author":"Mor","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13019","DOI":"10.1021\/bi701378g","article-title":"Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity","volume":"46","author":"Ahn","year":"2007","journal-title":"Biochemistry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of Anxiety through Blockade of Anandamide Hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1021\/jm400923s","article-title":"Chiral 1,3,4-Oxadiazol-2-Ones as Highly Selective FAAH Inhibitors","volume":"56","author":"Patel","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejps.2013.03.015","article-title":"1,3,4-Oxadiazol-2-Ones as Fatty-Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors: Synthesis, in Vitro Evaluation and Insight into Potency and Selectivity Determinants by Molecular Modelling","volume":"49","author":"Taupila","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"della Pietra, A., Giniatullin, R., and Savinainen, J.R. (2021). Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031204"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"113956","DOI":"10.1016\/j.physbeh.2022.113956","article-title":"Modelling Migraine-Related Features in the Nitroglycerin Animal Model: Trigeminal Hyperalgesia Is Associated with Affective Status and Motor Behavior","volume":"256","author":"Demartini","year":"2022","journal-title":"Physiol. Behav."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.bjp.0706699","article-title":"Inhibition of Fatty Acid Amide Hydrolase Produces Analgesia by Multiple Mechanisms","volume":"148","author":"Chang","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00482-003-0210-5","article-title":"Neuropeptide Release in the Dura Mater Encephali in Response to Nitric Oxide\u2014Relevance for the Development of Vascular Headaches?","volume":"17","author":"Strecker","year":"2003","journal-title":"Schmerz"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/brain\/124.12.2490","article-title":"Delayed Inflammation in Rat Meninges: Implications for Migraine Pathophysiology","volume":"124","author":"Reuter","year":"2001","journal-title":"Brain"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0306-4522(98)00366-2","article-title":"Release of Substance P, Calcitonin Gene-Related Peptide and Prostaglandin E2 from Rat Dura Mater Encephali Following Electrical and Chemical Stimulation in Vitro","volume":"89","author":"Ebersberger","year":"1999","journal-title":"Neuroscience"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0361-9230(94)00201-B","article-title":"Detailed Mapping of CGRP MRNA Expression in the Rat Central Nervous System: Comparison with Previous Immunocytochemical Findings","volume":"36","author":"Kresse","year":"1995","journal-title":"Brain Res. Bull."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0306-4522(03)00159-3","article-title":"Localization and Modulation of Calcitonin Gene-Related Peptide-Receptor Component Protein-Immunoreactive Cells in the Rat Central and Peripheral Nervous Systems","volume":"120","author":"Ma","year":"2003","journal-title":"Neuroscience"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1526-4610.2012.02262.x","article-title":"Two Mechanisms Involved in Trigeminal CGRP Release: Implications for Migraine Treatment","volume":"53","author":"Durham","year":"2013","journal-title":"Headache"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the Players: 2-Arachidonoylglycerol Synthesis and Degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Starowicz, K., Makuch, W., Korostynski, M., Malek, N., Slezak, M., Zychowska, M., Petrosino, S., De Petrocellis, L., Cristino, L., and Przewlocka, B. (2013). Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060040"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bjp.0706348","article-title":"Inhibitors of Fatty Acid Amide Hydrolase Reduce Carrageenan-Induced Hind Paw Inflammation in Pentobarbital-Treated Mice: Comparison with Indomethacin and Possible Involvement of Cannabinoid Receptors","volume":"146","author":"Holt","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2013.01.003","article-title":"Inhibition of FAAH and Activation of PPAR: New Approaches to the Treatment of Cognitive Dysfunction and Drug Addiction","volume":"138","author":"Panlilio","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","article-title":"Actions of the FAAH Inhibitor URB597 in Neuropathic and Inflammatory Chronic Pain Models","volume":"147","author":"Jayamanne","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/cr2002799","article-title":"Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways","volume":"111","author":"Rouzer","year":"2011","journal-title":"Chem. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.prostaglandins.2014.11.002","article-title":"Endocannabinoid Metabolism by Cytochrome P450 Monooxygenases","volume":"117","author":"Zelasko","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1194\/jlr.M021378","article-title":"Estimation of Reference Intervals of Five Endocannabinoids and Endocannabinoid Related Compounds in Human Plasma by Two Dimensional-LC\/MS\/MS","volume":"53","author":"Fanelli","year":"2012","journal-title":"J. Lipid Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10102\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:54:28Z","timestamp":1760126068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms241210102"],"URL":"https:\/\/doi.org\/10.3390\/ijms241210102","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]}}}